Article states that more than half of the 600 patents related to cannabis are held in China. Unclear if they relate to industrial hemp or medicinal uses.
The race to get coveted FDA approval is even more heated. If GW Pharmaceuticals' stock price is any indication, it may be first out the gate with its CBD-based epilepsy treatment, Epidiolex.
A powerful drug derived from marijuana is on the cusp of federal approval